Aurinia Pharmaceuticals to Present at the 11th Annual Leerink Global Healthcare Conference
February 03 2022 - 7:05AM
Business Wire
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (the “Company”)
today announced that the company will deliver a corporate
presentation at the 11th Annual Leerink Global Healthcare
Conference (February 14-18, 2022). The presentation will take place
virtually on Wednesday, February 16, 2022 at 8 am ET.
Interested parties can register to listen to the presentation via
the public link here or access via the Investor section of the
Aurinia corporate website - www.auriniapharma.com, under
"News/Events.”
ABOUT AURINIA
Aurinia is a fully integrated biopharmaceutical company focused
on delivering therapies to treat targeted patient populations that
are impacted by serious diseases with a high unmet medical need. In
January 2021, the Company introduced the first FDA-approved oral
therapy indicated for the treatment of adult patients with active
lupus nephritis (LN). Aurinia’s head office is in Victoria, British
Columbia; its U.S. commercial hub is in Rockville, Maryland; and
the Company focuses development efforts globally.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220203005261/en/
Investor and Corporate Contact: Dana Lynch, IR &
Corporate Communications dlynch@auriniapharma.com
Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From Apr 2023 to Apr 2024